Ramirez Asset Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-900
Closed -$115K – 394
2025
Q3
$115K Hold
900
– – 0.02% 237
2025
Q2
$109K Sell
900
-200
-18% -$22.5K 0.02% 239
2025
Q1
$123K Sell
1,100
-200
-15% -$21.3K 0.03% 234
2024
Q4
$127K Hold
1,300
– – 0.03% 246
2024
Q3
$150K Hold
1,300
– – 0.03% 223
2024
Q2
$138K Hold
1,300
– – 0.03% 230
2024
Q1
$126K Buy
+1,300
New +$133K 0.03% 252

Other funds holding NVS

Ramirez Asset Management's NVS Position: Q4 2025 in Review

Ramirez Asset Management sold out of Novartis (NVS) in Q4 2025, closing a stake of 900 shares — an estimated $115K sold.

Ramirez Asset Management first reported a position in NVS in Q1 2024 and held it in 7 quarters. The position peaked at $150K in Q3 2024. 1,515 funds tracked by Wall St. Rank hold NVS as of Q4 2025.

  • Ramirez Asset Management reported no remaining Novartis position as of Q4 2025 after selling out during the quarter.
  • Ramirez Asset Management sold 900 Novartis shares in Q4 2025, an estimated $115K.
  • Ramirez Asset Management first reported a position in Novartis in Q1 2024 and held it in 7 quarters.
  • Ramirez Asset Management's Novartis position peaked at $150K in Q3 2024.
  • 1,515 funds tracked by Wall St. Rank held Novartis as of Q4 2025.

Based on Ramirez Asset Management's 13F filing for Q4 2025, filed 11 Feb 2026.